OPNT
Opiant Pharmaceuticals, Inc.
Other OTC
People also watch:NTCTOIIMSPRTOTEXIPAR
7.83-0.15 (-1.88%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close7.98
Open7.98
Bid0.00 x
Ask0.00 x
52wk Range7.40 - 10.00
Day's Range7.83 - 8.01
Volume5,717
Avg Vol (3m)4,792
As of 3:32 PM EDT. Market closed.
  • The Wall Street Journalyesterday

    [$$] Wonder Workshop Raises $20M Series B for Educational Robots

    The company’s main products, the Dash and Dot robots, teach children computer science and coding fundamentals.

  • Opiant Pharmaceuticals, Inc. :OPNT-US: Earnings Analysis: Q2, 2016 By the Numbers : May 23, 2016
    Capital Cube2 months ago

    Opiant Pharmaceuticals, Inc. :OPNT-US: Earnings Analysis: Q2, 2016 By the Numbers : May 23, 2016

    Click here to see latest analysisOpiant Pharmaceuticals, Inc. reports financial results for the quarter ended January 31, 2016.We analyze the earnings along side the following peers of Opiant Pharmaceuticals, Inc. – GW Pharmaceuticals PLC Sponsored ADR and Arena Pharmaceuticals, Inc. (GWPH-US and ARNA-US) that have also reported for this period.HighlightsSummary numbers: Revenues of USD 6.86 […] (Read more...) The post Opiant Pharmaceuticals, Inc. :OPNT-US: Earnings Analysis: Q2, 2016 By the Numbers : May 23, 2016 appeared first on CapitalCube.